Biotech Values

[dewophile]

We frequently discuss tL as an overhang. But the lack of apparent movement of other products, pipeline or partnerships is at least as big a problem.

i think we all agree lack of tangible progress/partnering on rest of pipeline is weighing on the stock as well
i think CW could have put mC into the forefront even more - after stating typical ANDA review times he could have outright said that since they are at that point in time in review it could be a 2011 event - that kind of spin i can live with - let shorts sweat a little. also i didn't care for the whole bit on losing 180 day exclusivity - who cares, the assumption is mylan won't get approval and if they do mnta's IP woudl block them - less is more sometimes

i don't think FOB was weak - when he mentioned they were approached with partnering for single products but decided to look for broader partnership really helped convince me at least there is genuine interest in the technology and it is only a matter of time

M118 is what it is